Trials / Completed
CompletedNCT02519751
New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass
Total Body Skeletal Muscle Mass Estimation by Creatine (Methyl-d3) Dilution in Athletes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Creatine (methyl-d3) dilution (D3-creatine) is a novel technique for the estimation of muscle mass. The method uses a dose of deuterium-labelled creatine to determine total skeletal muscle mass via estimation of total body creatine pool size.The aim of this study is to compare estimates of total body skeletal muscle mass by D3-creatine dilution method and whole body Magnetic Resonance Imaging (MRI) in an athletic population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | D3 Creatine | One dose of D3 Creatine (60mg capsule) given orally on Day 1 |
| DIETARY_SUPPLEMENT | Creatine | Participants will consume an individual dosed level of creatine, based on their estimated muscle mass in doses of 0.03, 0.035, 0.04, 0.045 g.kg.Lean mass/day, increasing on a weekly basis. Final dose of 0.05 g.kg.Lean mass/day is then maintained throughout the study. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2015-08-11
- Last updated
- 2015-08-11
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02519751. Inclusion in this directory is not an endorsement.